Bakirtzi, K.
18  results:
Search for persons X
?
1

Anti‐interleukin‐17A biologics for the long‐term treatment ..:

Bakirtzi, K. ; Sotiriou, E. ; Papadimitriou, I....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  6 - p. , 2023
 
?
2

Real‐life intraclass switch among IL‐17 inhibitors in psori..:

Sotiriou, E. ; Bakirtzi, K. ; Papadimitriou, I....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  11 - p. , 2022
 
?
3

Long‐term drug survival of secukinumab in real life in the ..:

Sotiriou, E. ; Bakirtzi, K. ; Vakirlis, E....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  8 - p. , 2022
 
?
4

COVID‐19 vaccination intention among patients with psoriasi..:

Sotiriou, E. ; Bakirtzi, K. ; Papadimitriou, I....
British Journal of Dermatology.  185 (2021)  1 - p. 209-210 , 2021
 
?
5

A head‐to‐head comparison of risankizumab and ixekizumab fo..:

Sotiriou, E. ; Bakirtzi, K. ; Papadimitriou, I....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  5 - p. , 2021
 
?
6

Psoriasis exacerbation after COVID‐19 vaccination: a report..:

Sotiriou, E. ; Tsentemeidou, A. ; Bakirtzi, K....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  12 - p. , 2021
 
?
7

Psoriasis vs. its mimickers: when the dermatoscope casts li..:

Papadimitriou, I. ; Bakirtzi, K. ; Lallas, A....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  11 - p. , 2021
 
?
8

When the low may still be high: the heavy burden of residua..:

Bakirtzi, K. ; Sotiriou, E. ; Vakirlis, E....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  2 - p. , 2021
 
?
9

Teledermoscopy of common pink, flat and scaly lesions as an..:

Papadimitriou, I. ; Bakirtzi, K. ; Sotiriou, E....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  8 - p. , 2021
 
?
10

Delayed localized hypersensitivity reactions to COVID‐19 mR..:

Papadimitriou, I. ; Bakirtzi, K. ; Sotiriou, E....
Clinical and Experimental Dermatology.  47 (2021)  1 - p. 157-158 , 2021
 
?
11

Is apremilast for psoriasis as effective and safe as report..:

Sotiriou, E. ; Tsentemeidou, A. ; Vakirlis, E....
Clinical and Experimental Dermatology.  46 (2021)  8 - p. 1542-1544 , 2021
 
?
12

Treatment adherence in psoriatic patients during COVID‐19 p..:

Vakirlis, E. ; Bakirtzi, K. ; Papadimitriou, I....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  11 - p. , 2020
 
?
13

Has the migratory wave altered the fungal landscape in Gree..:

Papadimitriou, I. ; Bakirtzi, K. ; Sideris, N....
Journal of the European Academy of Dermatology and Venereology.  35 (2020)  4 - p. , 2020
 
?
14

Cathelicidin suppresses lipid accumulation and hepatic stea..:

Hoang-Yen Tran, D ; Hoang-Ngoc Tran, D ; Mattai, S A...
International Journal of Obesity.  40 (2016)  9 - p. 1424-1434 , 2016
 
?
15

Risk factors for actinic keratosis in eight European centre..:

Traianou, A. ; Ulrich, M. ; Apalla, Z....
British Journal of Dermatology.  167 (2012)  - p. 36-42 , 2012
 
1-15